Cellular cardiomyoplasty

Evidence of cellular therapy, mechanisms and controversies

Adil Al-Kindi, Yin Ge, Dominique Shum-Tim

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Cardiomyocytes are terminally differentiated cells that the heart cannot replace when they are damaged. A couple of decades ago, attempts were made to exogenously replace lost cardiac cells in hope of ultimately avoiding heart failure. However, despite promising initial results, the progress has been humble. One of the main limiting factors has been lack of clear understanding of the mechanism behind the functional improvement observed. Three main hypotheses emerged; the oldest is “trans-differentiation” which assumes that transplanted primitive cells need to differentiate to cardiac cells before contributing to the function. Evidence also supported “fusion”, in which transplanted cells fuse with primitive cardiac cells to improve cardiac function. However, due to the paucity of trans-differentiated or fused cells, it was thought that it was unlikely that these mechanisms are the sole contributors. Evidence has thus emerged that transplanted stem cells actually exert a paracrine effect on the surrounding cells and extracellular matrix with angiogenic, prosurvival and anti-inflammatory effects. In this chapter, we review the evidence behind the mechanisms of functional improvement in “cellular cardiomyoplasty” and carefully investigate the evidence and controversies behind transdifferentiation, fusion and paracrine hypotheses. Evidence from both in-vivo and in-vitro studies is explored.

Original languageEnglish
Title of host publicationStem Cell Bioengineering and Tissue Engineering Microenvironment
PublisherWorld Scientific Publishing Co.
Pages385-440
Number of pages56
ISBN (Electronic)9789812837899
ISBN (Print)9812837884, 9789812837882
DOIs
Publication statusPublished - Jan 1 2011

Fingerprint

Cardiomyoplasty
Fusion reactions
Electric fuses
Stem cells
Anti-Inflammatory Agents
Therapeutics
Cardiac Myocytes
Extracellular Matrix
Stem Cells
Heart Failure

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Al-Kindi, A., Ge, Y., & Shum-Tim, D. (2011). Cellular cardiomyoplasty: Evidence of cellular therapy, mechanisms and controversies. In Stem Cell Bioengineering and Tissue Engineering Microenvironment (pp. 385-440). World Scientific Publishing Co.. https://doi.org/10.1142/9789812837899_0014

Cellular cardiomyoplasty : Evidence of cellular therapy, mechanisms and controversies. / Al-Kindi, Adil; Ge, Yin; Shum-Tim, Dominique.

Stem Cell Bioengineering and Tissue Engineering Microenvironment. World Scientific Publishing Co., 2011. p. 385-440.

Research output: Chapter in Book/Report/Conference proceedingChapter

Al-Kindi, A, Ge, Y & Shum-Tim, D 2011, Cellular cardiomyoplasty: Evidence of cellular therapy, mechanisms and controversies. in Stem Cell Bioengineering and Tissue Engineering Microenvironment. World Scientific Publishing Co., pp. 385-440. https://doi.org/10.1142/9789812837899_0014
Al-Kindi A, Ge Y, Shum-Tim D. Cellular cardiomyoplasty: Evidence of cellular therapy, mechanisms and controversies. In Stem Cell Bioengineering and Tissue Engineering Microenvironment. World Scientific Publishing Co. 2011. p. 385-440 https://doi.org/10.1142/9789812837899_0014
Al-Kindi, Adil ; Ge, Yin ; Shum-Tim, Dominique. / Cellular cardiomyoplasty : Evidence of cellular therapy, mechanisms and controversies. Stem Cell Bioengineering and Tissue Engineering Microenvironment. World Scientific Publishing Co., 2011. pp. 385-440
@inbook{6cca617c9d354cb59785a6ba767be65c,
title = "Cellular cardiomyoplasty: Evidence of cellular therapy, mechanisms and controversies",
abstract = "Cardiomyocytes are terminally differentiated cells that the heart cannot replace when they are damaged. A couple of decades ago, attempts were made to exogenously replace lost cardiac cells in hope of ultimately avoiding heart failure. However, despite promising initial results, the progress has been humble. One of the main limiting factors has been lack of clear understanding of the mechanism behind the functional improvement observed. Three main hypotheses emerged; the oldest is “trans-differentiation” which assumes that transplanted primitive cells need to differentiate to cardiac cells before contributing to the function. Evidence also supported “fusion”, in which transplanted cells fuse with primitive cardiac cells to improve cardiac function. However, due to the paucity of trans-differentiated or fused cells, it was thought that it was unlikely that these mechanisms are the sole contributors. Evidence has thus emerged that transplanted stem cells actually exert a paracrine effect on the surrounding cells and extracellular matrix with angiogenic, prosurvival and anti-inflammatory effects. In this chapter, we review the evidence behind the mechanisms of functional improvement in “cellular cardiomyoplasty” and carefully investigate the evidence and controversies behind transdifferentiation, fusion and paracrine hypotheses. Evidence from both in-vivo and in-vitro studies is explored.",
author = "Adil Al-Kindi and Yin Ge and Dominique Shum-Tim",
year = "2011",
month = "1",
day = "1",
doi = "10.1142/9789812837899_0014",
language = "English",
isbn = "9812837884",
pages = "385--440",
booktitle = "Stem Cell Bioengineering and Tissue Engineering Microenvironment",
publisher = "World Scientific Publishing Co.",
address = "United States",

}

TY - CHAP

T1 - Cellular cardiomyoplasty

T2 - Evidence of cellular therapy, mechanisms and controversies

AU - Al-Kindi, Adil

AU - Ge, Yin

AU - Shum-Tim, Dominique

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Cardiomyocytes are terminally differentiated cells that the heart cannot replace when they are damaged. A couple of decades ago, attempts were made to exogenously replace lost cardiac cells in hope of ultimately avoiding heart failure. However, despite promising initial results, the progress has been humble. One of the main limiting factors has been lack of clear understanding of the mechanism behind the functional improvement observed. Three main hypotheses emerged; the oldest is “trans-differentiation” which assumes that transplanted primitive cells need to differentiate to cardiac cells before contributing to the function. Evidence also supported “fusion”, in which transplanted cells fuse with primitive cardiac cells to improve cardiac function. However, due to the paucity of trans-differentiated or fused cells, it was thought that it was unlikely that these mechanisms are the sole contributors. Evidence has thus emerged that transplanted stem cells actually exert a paracrine effect on the surrounding cells and extracellular matrix with angiogenic, prosurvival and anti-inflammatory effects. In this chapter, we review the evidence behind the mechanisms of functional improvement in “cellular cardiomyoplasty” and carefully investigate the evidence and controversies behind transdifferentiation, fusion and paracrine hypotheses. Evidence from both in-vivo and in-vitro studies is explored.

AB - Cardiomyocytes are terminally differentiated cells that the heart cannot replace when they are damaged. A couple of decades ago, attempts were made to exogenously replace lost cardiac cells in hope of ultimately avoiding heart failure. However, despite promising initial results, the progress has been humble. One of the main limiting factors has been lack of clear understanding of the mechanism behind the functional improvement observed. Three main hypotheses emerged; the oldest is “trans-differentiation” which assumes that transplanted primitive cells need to differentiate to cardiac cells before contributing to the function. Evidence also supported “fusion”, in which transplanted cells fuse with primitive cardiac cells to improve cardiac function. However, due to the paucity of trans-differentiated or fused cells, it was thought that it was unlikely that these mechanisms are the sole contributors. Evidence has thus emerged that transplanted stem cells actually exert a paracrine effect on the surrounding cells and extracellular matrix with angiogenic, prosurvival and anti-inflammatory effects. In this chapter, we review the evidence behind the mechanisms of functional improvement in “cellular cardiomyoplasty” and carefully investigate the evidence and controversies behind transdifferentiation, fusion and paracrine hypotheses. Evidence from both in-vivo and in-vitro studies is explored.

UR - http://www.scopus.com/inward/record.url?scp=84969730154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969730154&partnerID=8YFLogxK

U2 - 10.1142/9789812837899_0014

DO - 10.1142/9789812837899_0014

M3 - Chapter

SN - 9812837884

SN - 9789812837882

SP - 385

EP - 440

BT - Stem Cell Bioengineering and Tissue Engineering Microenvironment

PB - World Scientific Publishing Co.

ER -